Acyclovir

Prescription GLP-1 Therapy Information

This page provides general information about GLP-1 (glucagon-like peptide-1) receptor agonist injections. These are prescription medications used as part of a comprehensive approach to chronic weight management and metabolic health. The information provided is for educational purposes only and does not replace professional medical advice.

Critical Safety Notice

These are prescription medications. They are not available over-the-counter. A licensed healthcare provider must evaluate your medical history, current health status, and treatment goals to determine if a GLP-1 injection is appropriate for you. Do not use these medications without a valid prescription and proper medical supervision.

Understanding GLP-1 Therapy

GLP-1 receptor agonists are a class of medications that mimic the action of the natural GLP-1 hormone produced in the body. This hormone plays several important roles in metabolic regulation:

• Appetite Regulation: Acts on brain receptors to promote feelings of fullness and reduce food intake
• Slowed Gastric Emptying: Helps food move more slowly through the stomach, prolonging satiety
• Glucose-Dependent Insulin Release: Supports the bodys natural insulin response when blood sugar levels rise

What to Expect

• Prescription Required: Available only with a valid prescription from a licensed healthcare provider
• Injectable Medication: Administered via subcutaneous injection, typically once weekly or as prescribed
• Dose Titration: Starting doses are usually low and gradually increased over several weeks to minimize side effects
• Comprehensive Approach: Most effective when combined with a reduced-calorie diet and increased physical activity
• Ongoing Monitoring: Regular follow-ups with your healthcare provider are essential for safe and effective use

Important Safety Information

• Contraindications: Not recommended for individuals with a personal or family history of certain thyroid cancers or those with multiple endocrine neoplasia syndrome type 2 (MEN 2)
• Common Side Effects: May include nausea, vomiting, diarrhea, constipation, and abdominal discomfort, especially during dose initiation
• Serious Risks: Potential for pancreatitis, gallbladder disease, acute kidney injury, and severe gastrointestinal issues
• Not for Everyone: Not intended for use in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis
• Pregnancy & Breastfeeding: Safety during pregnancy and breastfeeding has not been established discuss with your doctor if you are planning to become pregnant

Administration Training

Proper training on injection technique is essential. Your healthcare provider or pharmacist will provide instructions on:

• How to prepare and administer the injection
• Proper storage of medication
• Rotation of injection sites
• Disposal of used needles and supplies